Mazo V K, Sidorova Yu S, Sharafetdinov Kh Kh, Kochetkova A A
Federal Research Centre of Nutrition, Biotechnology and Food Safety, Moscow.
Vopr Pitan. 2018;87(5):63-69. doi: 10.24411/0042-8833-2018-10054. Epub 2018 Sep 13.
The metabolic syndrome (MS), which is characterized by significant prevalence, constant growth of patients' number and high rate of cardiovascular complications, is one of actual problems of modern medicine. A way for optimization of the dietary status of patients with MS is the use of specialized foods with optimized chemical composition in their complex treatment. These products allow to correct hyperglycemia, dyslipidemia and antioxidant status disorders. The publications of the last decade show high interest of scientists to the problem of use of enzymatic hydrolysates of food proteins in dietary preventive products for people with metabolic disorders. High biological value of chicken egg protein and its enzymatic hydrolysates define the prospects of their use in specialized foods aimed at correction and/or prevention of MS clinical implications. The hydrolysis of chicken egg protein leads to the formation of biologically active peptides with antioxidant, hypotensive, anticoagulant and some other effects. As functional food ingredient, the enzymatic hydrolysate of chicken egg protein has some advantages over native protein - higher water solubility, digestibility and absorption in gastrointestinal tract. The results of preclinical in vitro and in vivo studies on evaluation of hypolipidemic effects of chicken egg protein and its enzymatic hydrolysates are discussed in this review. The analysis of the presented publications shows, that introduction of chicken egg protein and its enzymatic hydrolysates into the diet of animals with induced metabolic syndrome had hypolipidemic and antihypertensive effects. The main mechanisms of hypolipidemic action of protein hydrolysates and peptides in gastrointestinal tract are briefly discussed in this review. The prospects of the production of enzymatic hydrolysates of chicken egg protein with defined hypolipidemic properties for their inclusion into dietary products for prevention and treatment of MS are proved in the review.
代谢综合征(MS)具有显著的患病率、患者数量持续增长以及心血管并发症发生率高的特点,是现代医学面临的实际问题之一。优化MS患者饮食状况的一种方法是在其综合治疗中使用化学成分经过优化的特殊食品。这些产品有助于纠正高血糖、血脂异常和抗氧化状态紊乱。过去十年的出版物表明,科学家们对在代谢紊乱人群的膳食预防产品中使用食物蛋白的酶解产物问题高度关注。鸡蛋蛋白及其酶解产物具有很高的生物学价值,这决定了它们在旨在纠正和/或预防MS临床影响的特殊食品中的应用前景。鸡蛋蛋白的水解会产生具有抗氧化、降压、抗凝等多种作用的生物活性肽。作为功能性食品成分,鸡蛋蛋白的酶解产物比天然蛋白具有一些优势——更高的水溶性、消化率以及在胃肠道中的吸收率。本文综述了关于评估鸡蛋蛋白及其酶解产物降血脂作用的临床前体外和体内研究结果。对所呈现出版物的分析表明,将鸡蛋蛋白及其酶解产物引入诱导代谢综合征动物的饮食中具有降血脂和降压作用。本文还简要讨论了蛋白水解产物和肽在胃肠道中的降血脂作用主要机制。本文综述证实了生产具有明确降血脂特性的鸡蛋蛋白酶解产物并将其纳入预防和治疗MS的膳食产品中的前景。